Development and Multicenter Performance Evaluation of the First Fully Automated SARS-CoV-2 IgM and IgG Immunoassays

doi 10.1101/2020.04.16.20067231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cold Spring Harbor Laboratory

Related search

Accuracy of Rapid IgM and IgG Antibody Test for SARS-CoV-2 Infection Diagnosis: A Systematic Review and Meta Analysis

2020English

The Comparative Superiority of IgM-IgG Antibody Test to Real-Time Reverse Transcriptase PCR Detection for SARS-CoV-2 Infection Diagnosis

2020English

Fully Human Single-Domain Antibodies Against SARS-CoV-2

2020English

Rapid Diagnosis of SARS-CoV-2 Infection by Detecting IgG and IgM Antibodies With an Immunochromatographic Device: A Prospective Single-Center Study

2020English

SARS-COV-2 and Infectivity

Journal of Medical Virology
VirologyInfectious Diseases
2020English

Evaluation of Immunoglobulin M (IgM) and IgG Enzyme Immunoassays in Serologic Diagnosis of West Nile Virus Infection

Journal of Clinical Microbiology
Microbiology
2000English

Clinical Evaluation of a SARS-CoV-2 RT-PCR Assay on a Fully Automated System for Rapid On-Demand Testing in the Hospital Setting

2020English

Evaluation of the New Architect Cytomegalovirus Immunoglobulin M (IgM), IgG, and IgG Avidity Assays

Journal of Clinical Microbiology
Microbiology
2009English

The First-In-Class Peptide Binder to the SARS-CoV-2 Spike Protein

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy